Frier Levitt’s Post

The latest from 340B Report: Arkansas Begins Enforcement Against AstraZeneca for Allegedly Violating Contract Pharmacy Access Law - https://lnkd.in/djfxrbet CMS Finalizes Next Medicare Drug Negotiation Guidance Without Resolving Key Concerns of 340B Stakeholders - https://lnkd.in/djC78hnv Webinar—Neutral 340B Clearinghouse: Ready, Set, Now Go! - https://lnkd.in/dyMVQdCB Providers Praise Federal Court’s Defense of Louisiana Contract Pharmacy Law as Drug Industry Weighs Next Steps - https://lnkd.in/dGzxFkg5 State Contract Pharmacy Lawsuit Weekly Roundup: Updates on AbbVie, AstraZeneca Cases in Missouri - https://lnkd.in/dzE-N2cT To get full access to 340B Report news reporting and analysis, visit https://lnkd.in/gJd7qNyg #340B #pharmacy #drugpricing #hospitals #hospitalpharmacy #medicare

Mark Cuban. There are so many gray areas and fuzzy margins that insurance providers are NOT bringing up. They don’t want to jeopardize their business but escalating healthcare. The Care Custody and Control your employees expect for their health insurance has to be managed on continual basis. The rules change every year. If you are not paying attention your employees are the ones holding the bag. If you are not marketing or understanding your health insurance yearly your are at risk for negligence… the more you know! #fractionalhr #healthcarecosts #negligence

It's impossible for #CEOs and #founders to pay attention to ALL the details ALL the time. BUT, the details in this case matter…They matter a lot. Increases in the costs of #healthcare and reductions in coverage are born by employees. Yes, companies' costs go up as well, I get it. BUT, individual employees can’t absorb the 3-8% increase YOY while “gratefully” accepting reductions in coverage. The impact on employees’ bottom line is disproportionate to the impact on the corporate bottom line. Insurance is muddy. Insurance feels intimidating. Can you bury your head in the sand? No. Understand the decisions you are making and HOW they will affect your team. You can no longer say, “it’s insurance. What can we do about it?” There is a lot you can do about it, but you need to know the landscape. Get help understanding the decisions you signed up for. Learn to communicate the value your benefits bring to your team. Everyone is paying a fortune for benefits, we can at least ensure we are doing it INTENTIONALLY! -------------------------------------------------------- Nate & Co is not an insurance broker. We are an HR and People solutions consultancy. We help you articulate your strategy. We help you gain confidence in your benefits and HR. We keep you from wasting your employees' money on misaligned benefits. Follow us and Nate (me I am writing) if this struck a nerve with you. Keep an eye out for the upcoming new newsletter, “I Feel Like I Am Taking Crazy Pills? A look at HR today.”  #HRCONSULTANT #BENEFITSCONSULTANT 

Navigating Prescription Costs? Join our upcoming webinar! We know that prescriptions can add up quickly, which is why our next webinar is dedicated to Paying for Prescription Drugs. We'll guide you through what your insurance covers and explore various financial assistance options available to help you manage these costs: https://loom.ly/Ehs5wLI

Navigating Prescription Costs? Join Our Upcoming Webinar! We know that prescriptions can add up quickly, which is why our next webinar is dedicated to Paying for Prescription Drugs. We'll guide you through what your insurance covers and explore various financial assistance options available to help you manage these costs: https://loom.ly/Ehs5wLI

Last week, AbbVie filed a federal lawsuit, challenging Minnesota's new 340B contract pharmacy law, which went into effect July 1. In short, the law prohibits drug companies from denying 340B pricing to covered entities that contract with third party pharmacies to dispense medications, especially in rural areas. The law is modeled on an Arkansas law recently upheld by the Eighth Circuit Court of Appeals in PhRMA v. McClain. Throughout its complaint, AbbVie relitigates multiple claims that were soundly dismissed by the Eighth Circuit in McClain, including claims that state laws prohibiting 340B contract pharmacies pricing discrimination are preempted by federal law. AbbVie lodges numerous due process claims based on violations of the federal and state prohibitions of unconstitutional takings and a violation of Minnesota single subject and topic clause. AbbVie's complaint largely ignores the seemingly dispositive holding in McClain, especially in regard to the preemption claims. Instead, AbbVie makes a brief reference to McClain and attempts to distinguish it by claiming Minnesota covered entities do not retain title to 340B drugs when dispensed through a contract pharmacy. This claim is not only unsupported but is entirely false. To date, Pfizer and AbbVie have restored 340B pricing to covered entities utilizing contract pharmacies in MN. Will more manufacturers follow suit or refuse to comply? Looking forward to discussing more at #340BConf Check out McClain here - https://lnkd.in/gEK8T7sK Local coverage of federal lawsuit here - https://lnkd.in/gtjeZWUP

https://lnkd.in/eTkUPCGb Are you considering selling your medical devices & IVD devices in the European Union (EU)? Please remember there are obligations associated with Article 13 of Regulations (EU) 2017/745 (MDR) & (EU) 2017//746 (IVDR) concerning the importer. This is a relatively new regulatory role under the MDR/IVDR and comes into play when the manufacturer is located outside the EU. We offer a virtual importer service so the way you ship to the EU can remain unaffected. All checks and document reviews by Advena Services Ltd are completed remotely. We are currently onboarding new clients and welcome your enquiry. For more information click below to visit our website or email us at importer@advena.mt #mdr #mdrcompliance #article13 #article13importer #regulatorycompliance #regulatoryimporter #medicaldevices #medicaldeviceregulation #ivdr #regulations #euregulations

Nicole Corona and Ryan Magee spoke with Law360 about the DEA’s move to reclassify cannabis as a Schedule III substance and how the rescheduling could affect insurers when it comes to offering coverage to cannabis businesses. #cannabis #cannabislaw

Big changes are on the way for Medicare in 2025! 💊 A $2,000 out-of-pocket cap, the elimination of the 'donut hole,' and lower drug prices are just a few updates that will impact your prescription drug coverage. TAP Insurance Group is here to guide you through what these changes mean for you. Stay informed, stay prepared! Contact us today for more information. #medicare2025 #prescriptiondrugchanges #TAPInsuranceGroup #healthcareupdates #gettappedin

🚨 Reminder: Preferred Pharmacy Networks (PPN) Consultation Closing Soon! 🚨 The Ministry of Finance’s consultation on Preferred Pharmacy Networks (PPNs) in Ontario’s employer-sponsored drug insurance sector is coming to an end. If you haven’t shared your feedback yet, now’s the time! Your input is valuable in shaping the future of PPNs and how they impact access, costs, and pharmacy operations. 🗓 Feedback deadline: October 22, 2024 📧 Submit comments to: FIPUConsultations@ontario.ca Don’t miss this opportunity to have your say! #PPNConsultation #PharmacyNetwork #OntarioHealthcare #DrugInsurance #PharmacyServices #SpecialtyMedicine #HealthcareConsultation #PPN #HealthcareConsultation #DrugReimbursement #SpecialtyMedicine #HealthInsurance #HealthcarePolicy #PharmacyAccess #PatientCare